Farmaco-epidemiologie als instrument bij het beoordelen van geneesmiddelen. Wat er mis kan gaan, leren we in de praktiik

R. M.C. Herings

Farmaco-epidemiologie als instrument bij het beoordelen van geneesmiddelen. Wat er mis kan gaan, leren we in de praktiik

Translated title of the contribution: Practice shows what can go wrong. Pharmacoepidemiology as an instrument for assessing drugs

R. M.C. Herings

Epidemiology and Data Science (VUmc)

Research output: Contribution to journal › Review article › Academic › peer-review

2 Citations (Scopus)

Abstract

Despite randomized clinical trials and adverse reaction reporting schemes, the cost caused by adverse drug reactions is estimated to exceed 5 billion dollars in the Netherlands annually. Some examples illustrate why we fail to predict drug-induced morbidity both quantitatively and qualitatively.

Translated title of the contribution	Practice shows what can go wrong. Pharmacoepidemiology as an instrument for assessing drugs
Original language	Dutch
Pages (from-to)	1833-1836
Number of pages	4
Journal	Pharmaceutisch Weekblad
Volume	133
Issue number	49
Publication status	Published - 4 Dec 1998

Keywords

Adverse drug reaction reporting systems
Adverse effects
Clinical trials
Economies, pharmaceutical
Pharmacoepidemiology

Cite this

@article{e424566d936848babe2c0de32bff2a91,

title = "Farmaco-epidemiologie als instrument bij het beoordelen van geneesmiddelen. Wat er mis kan gaan, leren we in de praktiik",

abstract = "Despite randomized clinical trials and adverse reaction reporting schemes, the cost caused by adverse drug reactions is estimated to exceed 5 billion dollars in the Netherlands annually. Some examples illustrate why we fail to predict drug-induced morbidity both quantitatively and qualitatively.",

keywords = "Adverse drug reaction reporting systems, Adverse effects, Clinical trials, Economies, pharmaceutical, Pharmacoepidemiology",

author = "Herings, {R. M.C.}",

year = "1998",

month = dec,

day = "4",

language = "Dutch",

volume = "133",

pages = "1833--1836",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie",

number = "49",

}

TY - JOUR

T1 - Farmaco-epidemiologie als instrument bij het beoordelen van geneesmiddelen. Wat er mis kan gaan, leren we in de praktiik

AU - Herings, R. M.C.

PY - 1998/12/4

Y1 - 1998/12/4

N2 - Despite randomized clinical trials and adverse reaction reporting schemes, the cost caused by adverse drug reactions is estimated to exceed 5 billion dollars in the Netherlands annually. Some examples illustrate why we fail to predict drug-induced morbidity both quantitatively and qualitatively.

AB - Despite randomized clinical trials and adverse reaction reporting schemes, the cost caused by adverse drug reactions is estimated to exceed 5 billion dollars in the Netherlands annually. Some examples illustrate why we fail to predict drug-induced morbidity both quantitatively and qualitatively.

KW - Adverse drug reaction reporting systems

KW - Adverse effects

KW - Clinical trials

KW - Economies, pharmaceutical

KW - Pharmacoepidemiology

UR - http://www.scopus.com/inward/record.url?scp=0032483983&partnerID=8YFLogxK

M3 - Review article

SN - 0031-6911

VL - 133

SP - 1833

EP - 1836

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 49

ER -

Farmaco-epidemiologie als instrument bij het beoordelen van geneesmiddelen. Wat er mis kan gaan, leren we in de praktiik

Abstract

Keywords

Other files and links

Cite this